Product Name

  • Name

    Validamycin

  • EINECS 609-372-4
  • CAS No. 37248-47-8
  • Article Data6
  • CAS DataBase
  • Density 1.69 g/cm3
  • Solubility soluble in water, methanol, dioxane, dimethylformamide
  • Melting Point 130-135 °C
  • Formula C20H35NO13
  • Boiling Point 813.7 °C at 760 mmHg
  • Molecular Weight 497.497
  • Flash Point 445.9 °C
  • Transport Information
  • Appearance white powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 37248-47-8 (Validamycin)
  • Hazard Symbols
  • Synonyms (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5-;HSDB 6745;Validacin;Validamycin A;Valimon;
  • PSA 253.02000
  • LogP -6.36180

Synthetic route

7,2'',3'',4'',6''-penta-O-acetyl-2,3,4',5',6',7'-hexa-O-benzylvalidamycin A
86733-63-3

7,2'',3'',4'',6''-penta-O-acetyl-2,3,4',5',6',7'-hexa-O-benzylvalidamycin A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
With ammonia; sodium In tetrahydrofuran at -78℃; for 6h;
With ammonium chloride; sodium 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h; Multistep reaction;
validamycin A undeca-O-acetate
86733-64-4, 121468-80-2

validamycin A undeca-O-acetate

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
With sodium methylate In methanol for 5h; Ambient temperature;
validamycin A undecabenzyl ether
73482-11-8

validamycin A undecabenzyl ether

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
With ammonium chloride; sodium 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h; Multistep reaction;
D-Glucose
2280-44-6

D-Glucose

culture medium

culture medium

A

validamine
32780-32-8

validamine

B

valienamine
38231-86-6

valienamine

D

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
With Streptomyces hygroscopicus var. limoneus In water at 28℃; for 168h; Further byproducts.;
D-Glucose
2280-44-6

D-Glucose

culture medium

culture medium

A

validamine
32780-32-8

validamine

B

valienamine
38231-86-6

valienamine

C

validamycin A
37248-47-8

validamycin A

D

validamycin B

validamycin B

Conditions
ConditionsYield
With Streptomyces hygroscopicus var. limoneus In water at 28℃; for 168h; Further byproducts.;
2,3,4',5',6',7'-hexa-O-benzylvalidoxylamine A
86733-61-1

2,3,4',5',6',7'-hexa-O-benzylvalidoxylamine A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 55.7 percent / imidazole / CHCl3 / 40 h / Heating
2: 74.2 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 4.5 h / Ambient temperature
3: 1) sodium, 2) ammonium chloride / 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h
View Scheme
Multi-step reaction with 3 steps
1: 61 percent / imidazole / CHCl3 / 48 h / Heating
2: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
3: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
7-O-acetyl-2,3,4',5',6',7'-hexa-O-benzylvalidoxylamine A
86733-62-2

7-O-acetyl-2,3,4',5',6',7'-hexa-O-benzylvalidoxylamine A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 74.2 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 4.5 h / Ambient temperature
2: 1) sodium, 2) ammonium chloride / 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h
View Scheme
Multi-step reaction with 2 steps
1: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
2: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
2,3,4',5',6',7'-hexa-O-benzyl-4,7-O-benzylidenevalidoxylamine A
86756-42-5, 102131-10-2

2,3,4',5',6',7'-hexa-O-benzyl-4,7-O-benzylidenevalidoxylamine A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 59 percent / aq acetic acid (80percent) / 20 h / 60 °C
2: 55.7 percent / imidazole / CHCl3 / 40 h / Heating
3: 74.2 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 4.5 h / Ambient temperature
4: 1) sodium, 2) ammonium chloride / 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h
View Scheme
Multi-step reaction with 4 steps
1: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
2: 61 percent / imidazole / CHCl3 / 48 h / Heating
3: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
4: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
4,7-O-benzylidenevalidoxylamine A hexa-O-acetate
86733-60-0, 102131-09-9

4,7-O-benzylidenevalidoxylamine A hexa-O-acetate

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 1)methanolic sodium methoxyde (1M), 2) sodium hydride / 1) methanol, room temp., 50 min, 2) DMF, room temp., 23 h
2: 59 percent / aq acetic acid (80percent) / 20 h / 60 °C
3: 55.7 percent / imidazole / CHCl3 / 40 h / Heating
4: 74.2 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 4.5 h / Ambient temperature
5: 1) sodium, 2) ammonium chloride / 1) liq NH3, THF, -70 deg C, 4 h 20 min, 2) room temp., 4.5 h
View Scheme
1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene
114779-32-7

1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 75 percent / propan-2-ol / 110 h / 120 °C
2: 89 percent / sodium hydride, di-imidazolyl sulphone / dimethylformamide / 1.5 h / 50 °C
3: 91 percent / propan-2-ol / 4 h / 80 °C
4: 75 percent / H2 / Ranei nickel T-4 / dioxane; ethanol / 6 h / 60 °C
5: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
6: 61 percent / imidazole / CHCl3 / 48 h / Heating
7: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
8: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
(1aR,2S,3S,3aR,5R,7aS,7bR)-2,3-Bis-benzyloxy-5-phenyl-hexahydro-1,4,6-trioxa-cyclopropa[a]naphthalene
114779-35-0, 148347-66-4

(1aR,2S,3S,3aR,5R,7aS,7bR)-2,3-Bis-benzyloxy-5-phenyl-hexahydro-1,4,6-trioxa-cyclopropa[a]naphthalene

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 75 percent / propan-2-ol / 110 h / 120 °C
2: 89 percent / sodium hydride, di-imidazolyl sulphone / dimethylformamide / 1.5 h / 50 °C
3: 91 percent / propan-2-ol / 4 h / 80 °C
4: 75 percent / H2 / Ranei nickel T-4 / dioxane; ethanol / 6 h / 60 °C
5: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
6: 61 percent / imidazole / CHCl3 / 48 h / Heating
7: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
8: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
(1S,2R,5R,7R,8S,10S)-8,9-dibenzyloxy-11-<(1S)-(1,4,6/5)-4,5,6-tribenzyloxy-3-benzyloxymethylcyclohex-2enyl>-5-phenyl-4,6-dioxa-11-azatricyclo<8.1.0.0.2,7>undecane
117295-71-3

(1S,2R,5R,7R,8S,10S)-8,9-dibenzyloxy-11-<(1S)-(1,4,6/5)-4,5,6-tribenzyloxy-3-benzyloxymethylcyclohex-2enyl>-5-phenyl-4,6-dioxa-11-azatricyclo<8.1.0.0.2,7>undecane

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 91 percent / propan-2-ol / 4 h / 80 °C
2: 75 percent / H2 / Ranei nickel T-4 / dioxane; ethanol / 6 h / 60 °C
3: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
4: 61 percent / imidazole / CHCl3 / 48 h / Heating
5: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
6: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
2,3,4',5',6',7'-hexa-O-benzyl-4,5-O-benzyllidenevalidoxylamine B
117320-21-5

2,3,4',5',6',7'-hexa-O-benzyl-4,5-O-benzyllidenevalidoxylamine B

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 89 percent / sodium hydride, di-imidazolyl sulphone / dimethylformamide / 1.5 h / 50 °C
2: 91 percent / propan-2-ol / 4 h / 80 °C
3: 75 percent / H2 / Ranei nickel T-4 / dioxane; ethanol / 6 h / 60 °C
4: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
5: 61 percent / imidazole / CHCl3 / 48 h / Heating
6: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
7: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
2,3,4',5',6',7'-hexa-O-benzyl-4,7-O-benzylidene-6-p-toluenesulphenylvalidoxylamine A
117295-72-4

2,3,4',5',6',7'-hexa-O-benzyl-4,7-O-benzylidene-6-p-toluenesulphenylvalidoxylamine A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 75 percent / H2 / Ranei nickel T-4 / dioxane; ethanol / 6 h / 60 °C
2: 86 percent / aq. 80percent acetic acid / 9 h / 50 °C
3: 61 percent / imidazole / CHCl3 / 48 h / Heating
4: 84 percent / silver trifluoromethanesulphonate, 1,1,3,3-tetramethylurea / CH2Cl2 / 10 h / Ambient temperature
5: liquid ammonia, sodium / tetrahydrofuran / 6 h / -78 °C
View Scheme
uridine 5′-diphosphate glucose disodium salt

uridine 5′-diphosphate glucose disodium salt

(+)-validoxylamine A
38665-10-0

(+)-validoxylamine A

validamycin A
37248-47-8

validamycin A

Conditions
ConditionsYield
With recombinant His6-tagged validamycin glycosyltransferase at 30℃; pH=7.5; aq. buffer; Enzymatic reaction;
acetic anhydride
108-24-7

acetic anhydride

validamycin A
37248-47-8

validamycin A

validamycin A undeca-O-acetate
86733-64-4, 121468-80-2

validamycin A undeca-O-acetate

Conditions
ConditionsYield
In pyridine Ambient temperature;60%
Yield given;
validamycin A
37248-47-8

validamycin A

1L-(1,2,4/3)-1-Methyl-2,3,4-cyclohexantriol
92621-62-0

1L-(1,2,4/3)-1-Methyl-2,3,4-cyclohexantriol

Conditions
ConditionsYield
(reduction);
validamycin A
37248-47-8

validamycin A

5a-carba-1,5-anhydro-L-iditol
139561-46-9

5a-carba-1,5-anhydro-L-iditol

Conditions
ConditionsYield
(reduction);
benzyl bromide
100-39-0

benzyl bromide

validamycin A
37248-47-8

validamycin A

validamycin A undecabenzyl ether
73482-11-8

validamycin A undecabenzyl ether

Conditions
ConditionsYield
With sodium hydride 1) DMF, r.t., 1 h, 2) r.t., 23 h; Yield given. Multistep reaction;
2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

acetic anhydride
108-24-7

acetic anhydride

validamycin A
37248-47-8

validamycin A

A

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-valienamine-3-aldehyde
223608-50-2

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-valienamine-3-aldehyde

B

Acetic acid (1S,2S,3R,4S,6S)-2,3-diacetoxy-6-tert-butoxycarbonylamino-4-formyl-cyclohexyl ester

Acetic acid (1S,2S,3R,4S,6S)-2,3-diacetoxy-6-tert-butoxycarbonylamino-4-formyl-cyclohexyl ester

Conditions
ConditionsYield
Multistep reaction;A 8 mg
B n/a
2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

acetic anhydride
108-24-7

acetic anhydride

validamycin A
37248-47-8

validamycin A

A

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-valienamine

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-valienamine

B

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-validamine

N-(tert-butyloxycarbonyl)-4,5,6-tri-O-acetyl-validamine

Conditions
ConditionsYield
Multistep reaction. Title compound not separated from byproducts;
2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

acetic anhydride
108-24-7

acetic anhydride

validamycin A
37248-47-8

validamycin A

mono-4-methoxytrityl chloride
14470-28-1

mono-4-methoxytrityl chloride

A

N-(tert-butoxycarbonyl)-4,5,6-tri-O-acetyl-7-(4-monomethoxytrityl)-valienamine

N-(tert-butoxycarbonyl)-4,5,6-tri-O-acetyl-7-(4-monomethoxytrityl)-valienamine

B

N-(tert-butoxycarbonyl)-4,5,6-tri-O-acetyl-7-(4-monomethoxytrityl)-validamine

N-(tert-butoxycarbonyl)-4,5,6-tri-O-acetyl-7-(4-monomethoxytrityl)-validamine

Conditions
ConditionsYield
Multistep reaction. Title compound not separated from byproducts;
validamycin A
37248-47-8

validamycin A

A

(+)-validoxylamine A
38665-10-0

(+)-validoxylamine A

B

validamine
32780-32-8

validamine

C

valienamine
38231-86-6

valienamine

Conditions
ConditionsYield
With ammonium sulfate; Flavobacterium saccharophilum IFO 13984; magnesium sulfate In phosphate buffer for 96h; pH=7.1; Hydrolysis; Title compound not separated from byproducts;
2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

validamycin A
37248-47-8

validamycin A

N-(tert-butyloxycarbonyl)-valienamide
85240-37-5

N-(tert-butyloxycarbonyl)-valienamide

A

N-(tert-butyloxycarbonyl)-7-(4-monomethoxytrityl)-valienamine

N-(tert-butyloxycarbonyl)-7-(4-monomethoxytrityl)-valienamine

B

N-(tert-butyloxycarbonyl)-7-(4-monomethoxytrityl)-validamine

N-(tert-butyloxycarbonyl)-7-(4-monomethoxytrityl)-validamine

Conditions
ConditionsYield
Stage #1: validamycin A With ammonium sulfate; Flavobacterium saccharophilum IFO 13984; magnesium sulfate In phosphate buffer for 96h; pH=7.1; Hydrolysis;
Stage #2: 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile In 1,4-dioxane; water at 20℃; Acylation;
Stage #3: N-(tert-butyloxycarbonyl)-valienamide With dmap; triethylamine In dichloromethane at 20℃; for 168000h; Etherification; Title compound not separated from byproducts;
2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

validamycin A
37248-47-8

validamycin A

A

N-(tert-butyloxycarbonyl)-valienamide
85240-37-5

N-(tert-butyloxycarbonyl)-valienamide

B

N-(tert-butyloxycarbonyl)-validamine

N-(tert-butyloxycarbonyl)-validamine

Conditions
ConditionsYield
Stage #1: validamycin A With ammonium sulfate; Flavobacterium saccharophilum IFO 13984; magnesium sulfate In phosphate buffer for 96h; pH=7.1; Hydrolysis;
Stage #2: 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile In 1,4-dioxane; water at 20℃; Acylation; Title compound not separated from byproducts;
validamycin A
37248-47-8

validamycin A

(+)-validoxylamine A
38665-10-0

(+)-validoxylamine A

Conditions
ConditionsYield
With acid
With sulfuric acid; acetic acid Inert atmosphere;
validamycin A
37248-47-8

validamycin A

C21H29NO8
1316288-57-9

C21H29NO8

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid; acetic acid / Inert atmosphere
2: toluene-4-sulfonic acid / N,N-dimethyl-formamide / 3 h / 60 °C / Inert atmosphere
View Scheme
validamycin A
37248-47-8

validamycin A

A

1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene
114779-32-7

1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene

B

2,3,4,7-tetra-O-benzylvalidamine
139499-19-7

2,3,4,7-tetra-O-benzylvalidamine

C

(2R,3S,4R,5R)-2,3,4-tris(benzyloxy)-5-[(benzyloxy)methyl]cyclohexanone
124330-57-0

(2R,3S,4R,5R)-2,3,4-tris(benzyloxy)-5-[(benzyloxy)methyl]cyclohexanone

D

(4R,5S,6R)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)-2-cyclohexen-1-one
110391-10-1

(4R,5S,6R)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)-2-cyclohexen-1-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sulfuric acid; acetic acid / Inert atmosphere
2: sodium hydride / N,N-dimethyl-formamide / Inert atmosphere
3: N-Bromosuccinimide / water; acetonitrile / 15 h / 20 °C / Inert atmosphere
View Scheme
validamycin A
37248-47-8

validamycin A

((1R,2R,3S,4S,5S)-2,3,4-tris(benzyloxy)-5-(((1S,4R,5S,6S)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)cyclohex-2-en-1-yl)amino)cyclohexyl)methanol
137063-37-7

((1R,2R,3S,4S,5S)-2,3,4-tris(benzyloxy)-5-(((1S,4R,5S,6S)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)cyclohex-2-en-1-yl)amino)cyclohexyl)methanol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sulfuric acid; acetic acid / Inert atmosphere
2.1: toluene-4-sulfonic acid / N,N-dimethyl-formamide / 3 h / 60 °C / Inert atmosphere
3.1: sodium hydride / N,N-dimethyl-formamide / 0.5 h / 0 °C / Inert atmosphere
3.2: 3 h / 20 °C / Inert atmosphere
4.1: diisobutylaluminium hydride / hexane; dichloromethane / 6.5 h / 0 - 20 °C / Inert atmosphere
View Scheme
validamycin A
37248-47-8

validamycin A

(4aR,6S,7S,8S,8aR)-7,8-bis(benzyloxy)-2-phenyl-N-((1S,4R,5S,6S)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)cyclohex-2-en-1-yl)hexahydro-4H-benzo[d][1,3]dioxin-6-amine
86756-42-5, 102131-10-2

(4aR,6S,7S,8S,8aR)-7,8-bis(benzyloxy)-2-phenyl-N-((1S,4R,5S,6S)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)cyclohex-2-en-1-yl)hexahydro-4H-benzo[d][1,3]dioxin-6-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sulfuric acid; acetic acid / Inert atmosphere
2.1: toluene-4-sulfonic acid / N,N-dimethyl-formamide / 3 h / 60 °C / Inert atmosphere
3.1: sodium hydride / N,N-dimethyl-formamide / 0.5 h / 0 °C / Inert atmosphere
3.2: 3 h / 20 °C / Inert atmosphere
View Scheme

Validamycin Specification

The Validamycin with CAS registry number of 37248-47-8 is also known as D-Chiro-Inositol,1,5,6-trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-[[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-,[1S-(1a,4a,5b,6a)]-. The IUPAC name is (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. It belongs to product categories of Fungicide. In addition, the formula is C20H35NO13 and the molecular weight is 497.49. This chemcial is a white powder and should be stored at the temperature of 0-6 °C. It is extracted and  made from variant and ferment of water streptomycin.

Physical properties about Validamycin are: (1)# of Rule of 5 Violations: 2; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 1; (5)ACD/KOC (pH 7.4): 1; (6)#H bond acceptors: 14; (7)#H bond donors: 12; (8)#Freely Rotating Bonds: 18; (9)Index of Refraction: 1.689; (10)Molar Refractivity: 111.91 cm3; (11)Molar Volume: 292.9 cm3; (12)Surface Tension: 112.4 dyne/cm; (13)Density: 1.69 g/cm3; (14)Flash Point: 445.9 °C; (15)Enthalpy of Vaporization: 134.65 kJ/mol; (16)Boiling Point: 813.7 °C at 760 mmHg; (17)Vapour Pressure: 1.17E-30 mmHg at 25 °C.

Uses of Validamycin: it is used as microbial fungicide. Besides, it is mainly for control of rice sheath blight, both protection and treatment. This chemical is also used to rid pellet sclerotinia, corn leaf blight, damping-off and root rot of vegetables, blight of cotton, bean, ginseng and so on.

You can still convert the following datas into molecular structure:
1. SMILES: OC/C3=C/[C@H](N[C@H]2C[C@H](CO)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]3O
2. InChI: InChI=1/C20H35NO13/c22-3-6-1-8(12(26)15(29)11(6)25)21-9-2-7(4-23)19(17(31)13(9)27)34-20-18(32)16(30)14(28)10(5-24)33-20/h1,7-32H,2-5H2/t7-,8+,9+,10-,11+,12+,13+,14-,15+,16+,17-,18-,19-,20+/m1/s1
3. InChIKey: JARYYMUOCXVXNK-IMTORBKUBD
4. Std. InChI: InChI=1S/C20H35NO13/c22-3-6-1-8(12(26)15(29)11(6)25)21-9-2-7(4-23)19(17(31)13(9)27)34-20-18(32)16(30)14(28)10(5-24)33-20/h1,7-32H,2-5H2/t7-,8+,9+,10-,11+,12+,13+,14-,15+,16+,17-,18-,19-,20+/m1/s1
5. Std. InChIKey: JARYYMUOCXVXNK-IMTORBKUSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 13gm/kg (13000mg/kg)   Japan Pesticide Information. Vol. (47), Pg. 17, 1985.
mouse LD50 intravenous > 13gm/kg (13000mg/kg)   Japan Pesticide Information. Vol. (15), Pg. 28, 1973.
mouse LD50 oral 2gm/kg (2000mg/kg)   "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 1, Pg. 229, 1980.
mouse LD50 subcutaneous > 15gm/kg (15000mg/kg)   Japan Pesticide Information. Vol. (47), Pg. 17, 1985.
rat LC50 inhalation > 5gm/m3 (5000mg/m3)   Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. Vol. 17, Pg. S29, 1992.
rat LD50 intraperitoneal 10gm/kg (10000mg/kg)   Japan Pesticide Information. Vol. (47), Pg. 17, 1985.
rat LD50 intravenous 7200mg/kg (7200mg/kg)   Japan Pesticide Information. Vol. (47), Pg. 17, 1985.
rat LD50 oral > 20gm/kg (20000mg/kg)   Japan Pesticide Information. Vol. (15), Pg. 28, 1973.
rat LD50 skin > 5gm/kg (5000mg/kg)   Japan Pesticide Information. Vol. (40), Pg. 32, 1982.
rat LD50 subcutaneous > 15gm/kg (15000mg/kg)   Japan Pesticide Information. Vol. (47), Pg. 17, 1985.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View